Axin2, BRAF, BRAFT1799A, BRAFV600E, BRAFV600E lung organoids, BRAFV600E oncoprotein, BRAFV600E-driven lung tumors, BRAFV600E/RBMS3Null lung tumors, Cancer, Cas9, Ccnd1, Ctnnb1, Ctnnb1, Ccnd1, Axin2, Lgr5, and c-Myc mRNAs, EGFRL858R, Lgr5, RBMS3, RBMS3Null, Rbms3, Sleeping Beauty, WNT, WNT ligands, acyltransferase, benign, benign lung tumors, c-Myc mRNAs, chromosome 3p24, dabrafenib, human, lung adenocarcinomas, lung cancer, lung cancers, lung tumors, malignant lung adenocarcinoma, malignant lung cancers, mouse, mutant BRAF, mutant BRAF-, non-small cell lung cancer, patient, patients, porcupine, trametinib, tumor, tumors